Condition

Hereditary Breast/Ovarian Cancer (brca1, brca2)

ClinicalTrials.gov condition label

Clinical trials8
Recruiting1
Common interventions20
Lead sponsors shown8

Clinical trials

8 shown
Specimen and Data Study for Ovarian Cancer Early Detection and PreventionNCT00005095 · 2000-03-01
RECRUITING
Evaluation of Well Being and Patient Reported Outcomes After Robotic Single-port Nipple Sparing Mastectomy and Implant ReconstructionNCT07236359 · 2025-12-31
NOT_YET_RECRUITING
Patient Centered Clinical Decision Support for Hereditary Cancer SyndromesNCT06914726 · 2025-07-09
ENROLLING_BY_INVITATION
Outcomes After Perforator Flap Reconstruction for Breast Reconstruction and/or Lymphedema TreatmentNCT01273909 · 2010-07-01
UNKNOWN
Letrozole in Preventing Breast Cancer in Postmenopausal Women With a BRCA1 or BRCA2 MutationNCT00673335 · 2008-05-01
COMPLETED
Standard Genetic Counseling With or Without a Decision Guide in Improving Communication Between Mothers Undergoing BRCA1/2 Testing and Their Minor-Age ChildrenNCT00685256 · 2008-03-01
COMPLETED
Carboplatin or Docetaxel in Treating Women With Metastatic Genetic Breast CancerNCT00321633 · 2005-09-01
COMPLETED
Arzoxifene or Tamoxifen in Preventing Breast Cancer in Premenopausal Women at High Risk for Breast CancerNCT00253539 · 2002-01-01
COMPLETED

Common interventions

arzoxifene hydrochlorideDRUG1Ca-125OTHER1carboplatinDRUG1counseling interventionOTHER1docetaxelDRUG1educational interventionOTHER1InterventionPROCEDURE1letrozoleDRUG1Patient Centered Clinical Decision Support (PC-CDS)OTHER1Perforator Flap Breast ReconstructionPROCEDURE1PlaceboDRUG1placeboOTHER1psychosocial assessment and careBEHAVIORAL1screening questionnaire administrationOTHER1Standard open nipple sparing mastectomy with immediate implant-based reconstructionPROCEDURE1supportive careBEHAVIORAL1SurgeryPROCEDURE1survey administrationOTHER1tamoxifen citrateDRUG1Vascularized Lymph Node TransferPROCEDURE1

Trial status mix

COMPLETED4
ENROLLING_BY_INVITATION1
NOT_YET_RECRUITING1
RECRUITING1
UNKNOWN1

Phase mix

NA2
PHASE22
PHASE32

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.